This Day On The Street
Continue to site right-arrow
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

Regence, Adventist Health Announce Next Step In Collaborative Care Initiatives

PORTLAND, Ore., April 26, 2013 /PRNewswire/ -- Regence BlueCross BlueShield of Oregon and Adventist Health have taken another step in advancing the health of patients and their experience with the Adventist health care system. Regence and Adventist are collaborating on an innovative payment model to deliver better health outcomes and lower health care costs.  This is Regence's first accountable health care initiative in Oregon and one of many arrangements in development within the Regence family of companies in Oregon, Washington, Idaho and Utah.

The program with Adventist Health's physicians includes a shared incentive arrangement in which Adventist Health and Regence will work together to share data and measure quality in an effort to improve health care outcomes for Regence members cared for at Adventist Health.

"Regence is committed to transforming the health care system through innovative collaborative care programs," said Richard Popiel, M.D., executive vice president of Health Care Services and chief medical officer for Regence. "Adventist Health is a strong partner, who invests in population health to meet the Triple Aim goals of improving the experience of care, improving the health of populations, and reducing per-capita costs of health care. It is exciting to be working with a partner deeply committed to the care of its patients."

This new initiative is part of a suite of innovative reimbursement models offered by Regence to address the quality and affordability of health care services for its members. Since 2007, Regence has worked with providers and employers throughout its four-state region to implement collaborative care models, including the Intensive Outpatient Care Program (IOCP) in Washington. The IOCP was a pilot program between Regence BlueShield in Washington and one of its large customers that demonstrated the following positive results as reported by an independent third party vendor: 

  • Per-capita spending on health care was reduced by 20 percent
  • Physical and mental functioning ability increased almost 15 percent
  • Access to health care increased almost 18 percent

In Oregon, Regence has collaborated with providers, such as Adventist Health, and employers to implement similar programs. Adventist Health is ranked as one of America's Safest Hospitals, and is an important provider in Regence's Oregon Select network, which provides Regence members with quality care and monthly premium affordability.

"We are pleased to further our collaboration with Adventist Health to improve health outcomes for our members and to support the physician-patient relationship that's critical to the transformation of the health care system," said Don Antonucci, president of Regence BlueCross BlueShield of Oregon.

"We are looking forward to a healthy collaboration with Regence which will bring value, access and quality care to patients and is firmly grounded in our mission of whole person care," states Tom Russell, President and CEO of Adventist Health-Portland. "This accountable care relationship will allow our providers increased transparency around utilization and quality measures."

Regence is currently developing additional collaborative arrangements with doctors and hospitals in a variety of ways that adapt to and support the readiness of providers to engage in these models. The company will soon announce new collaborative care arrangements in other states.

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Jim Cramer and Stephanie Link reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

Jim Cramer's protégé, David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
Try it NOW
Try it NOW
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

Jim Cramer's protégé, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!


DOW 17,191.37 -195.84 -1.13%
S&P 500 2,002.16 -27.39 -1.35%
NASDAQ 4,637.9940 -43.5030 -0.93%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs